期刊文献+

8-氯腺苷诱导的组蛋白H3K79双甲基化促进NBS1和p21的基因转录激活 被引量:1

8-Chloro-adenosine-induced H3K79me2 Promotes Transcriptional Activation of NBS1 and p21 Genes in Response to DNA Double-stranded Breaks
下载PDF
导出
摘要 组蛋白H3第79位赖氨酸甲基化(H3K79me)修饰有单甲基、双甲基及三甲基3种形式,是常染色质的标志.然而,对于组蛋白H3K79三种甲基化各自在基因转录、DNA损伤修复中所起的作用尚不十分清楚.本研究以8-氯腺苷(8-Cl-Ado)为DNA双链断裂(DNAdouble-stranded breaks,DSB)诱导剂,采用Western印迹,在人肺癌细胞H1299检测出了DNA修复分子NBS1、细胞周期检验点相关分子p21,并发现H3K79me1、H3K79me2和H3K79me3三种甲基化修饰的组蛋白明显增加;染色质免疫共沉淀结合实时定量PCR实验显示,只有H3K79me2与DNA损伤检验点分子p21、DNA修复分子NBS1的启动子区域相结合,说明H3K79双甲基化修饰与这些基因的转录激活有关.结果提示,在8-氯腺苷引起DSB时,是H3K79me2、而不是H3K79me1和H3K79me3参与NBS1和p21基因转录激活时的染色质重塑.8-氯腺苷诱导H3K79双甲基化增强、促进H3K79me2所在染色质区域的NBS1和p21基因转录激活可能是8-Cl-Ado抑制肿瘤细胞生长作用机制之一. Methylation of H3K79, including mono, di and trimethyled H3K79 (H3K79me1, H3K79me2 and H3K79me3), is one of the landmark modifications associated with euehromatin. However, the roles of methylated H3K79 in gene regulation, DNA damage and repair are unclear. In this study, we showed that the levels of NBS1 (a DNA damage response protein), p21 (a DNA damage checkpoint protein), and three methylated H3K79 were markedly up-regulated in 8-Cl-Ado-exposed H1299 cells, evidenced by Western blotting. The combination of chromatin immunoprecipitation (CHIP) with real-time quantitative PCR (RT-qPCR) revealed that only H3K79me2 was associated with the NBS1 and p21 promoters, indicating the contribution of H3K79me2, to transcriptional activation of these genes. These results suggest that H3K79me2, but not H3K79me1 and H3K79me3, is involved in the chromatin remodeling associated with the transcription activation of the NBS1 and p21 genes. Induction of H3K79me2 by 8-Cl-Ado in the chromatin surrounding the NBS1 and p21 genes may be a way by that 8-Cl-Ado inhibits tumor cell proliferation.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2009年第11期1035-1040,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金委项目(No.30471975,30671062) 北京市教委人才强教计划项目资助~~
关键词 8-氯腺苷 DNA双链断裂 H3K79甲基化 NBS1 P21 表观遗传调控 8-Cl-Ado DNA double-stranded breaks H3K79me NBS1 p21 epigenetic control
  • 相关文献

参考文献27

  • 1Strahi BD, Allis CD. The language of covalent histone modification [J]. Nat 2000, 403(6765): 41-45.
  • 2Whetztine JR, Nottke A, Lan F, et al. Reversal of historic Iysine trimethylation by the JMJD2 family of histone demethylases [ J ]. Cell, 2006, 125(3): 467-481.
  • 3Jenuwein T, Allis CD. Translating the histone code [J]. Science, 2001, 293(5532) : 1074-1080.
  • 4Lachner M, Jenuwein T. The many faces of histone lysine methlation [J]. Curr Opin Cell Biol, 2002, 14(3) : 286-298.
  • 5Schubele D, Mac Alpine D M, Scalzo D, et al. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a highereukaryote [ J ]. Genes Dev, 2004, 18 (11) : 1263-1271.
  • 6Shanower GA, Muller M, Blanton J L, et al. Characterization of the grappa gene, the Drosophila histone H3 lysine 79 methyltransferase [J]. Genetics, 2005, 169(1) : 173-184.
  • 7Huyen Y, Zgheib O, DiTullio RA Jr, et al. Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks [J]. Nature, 2004, 432(7015): 406-411.
  • 8Giannattasio M, Lazzaro F, Plevani P, et al. The DNA damage checkpoint response requires histone H2B ubiquitination by Rad6- Brel and H3 methylation by Dotl [J]. J Biol Chem, 2005, 280 (11) : 9879-9886.
  • 9Wysocki R, Javaheri A, Allard S, et al. Role of Dotl-dependent histone H3 methylation in Gland S phase DNA damage checkpoint functions of Rad9 [J]. Mol Cell Biol, 2005, 25 (19) : 8430-8443.
  • 10Stellrecht CM, Rodriguez CO, Jr, Ayres M, et al. RNA-directed actions of 8-choro-adenosine in multiple myeloma cells [J]. Cancer Res, 2003, 63(22): 7968-7974.

二级参考文献47

  • 1朱玄,安国顺,李淑艳,潘颖,倪菊华,贾弘禔.八氯腺苷诱导SH-SY5Y和SK-N-SH细胞G_2/M期阻滞的分子机制不同[J].中国生物化学与分子生物学报,2006,22(7):584-590. 被引量:4
  • 2Gu Y Y, Zhang H Y, Zhang H J, et al. 8-Chloro-adenosine inhibits growth at least partly by interfering with actin polymerization in cultured human lung cancer cells[J]. Biochem Pharmacol, 2006, 72 (5) : 541-550
  • 3Crawford D F, Piwnica-Wonns H. The G2 DNA damage checkpoint delays expression of genes encoding mitotic regulators [ J ]. J Biol Chem, 2001, 276(40): 37166-37177
  • 4Kawabe T. G2 checkpoint abrogators as anticancer drugs [ J ]. Mol Cancer Ther, 2004, 3(4): 513-519
  • 5Kohn E A, Yoo C J, Eastman A. The protein kinase C inhibitor Goo6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints [J]. Cancer Res, 2003, 63( 1 ) : 31-35
  • 6Lange-Carter C A, Vuillequez J J, Malkinso A M. 8-Chloroadenosine mediates 8-chloro-cyclic AMP-induced down-regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism[J]. Cancer Res, 1993, 53(2): 393-400
  • 7Ciardiello F, Damiano V, Bianeo R, et al. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A[J]. J Natl Cancer Inst, 1996, 88(23) : 1770-1776
  • 8Ahn Y H, Jung J M, Hong S H. 8-Chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells [J]. Cancer Res, 2005, 65 ( 11 ) : 4896-4901
  • 9Takagaki K, Katsuma S, Kaminishi Y, et al. Role of Chkl and Chk2 in Ara-C-induced differentiation of human leukemia K562 cells [J]. Genes Cells, 2005, 10(2): 97-106
  • 10Kitagawa R, Bakkenist C J, McKinnon P J, et al. Phosphorylation of SMCI is a critical downstream event in the ATM-NBSI-BRCA1 pathway[J]. Gene Dev, 2004, 18(12) : 1423-1438

共引文献8

同被引文献11

  • 1朱文玲.腺苷在心血管病诊治中的应用前景[J].中华心血管病杂志,2004,32(10):948-951. 被引量:17
  • 2Robak T. New nucleoside analogs for patients with he-matological malignancies[ J]. Expert Opinion on Inves-tigational Drugs,2011,20(3) :343 -359.
  • 3Tran H, Yang D_ Qofarabine in the treatment of newlydiagnosed acute myeloid leukemia in older adults [J]. HieAnnals of Phannacolherapy ,2012,46( 1) :89 - 96.
  • 4Schreiner T L, Miravalle A. Current and emerging(6)Schreiner T L, Miravalle A. Current and emergingtherapies for the treatment of multiple sclerosis : Focuson cladribine [ J ] ? Journal of central nervous systemdisease ,2012,4:1 - 14.
  • 5Polotskaia K, Hoffman S, Krett N L, et al. 8-amino-adenosine activates p53-independent cell death of me-tastatic breast cancers [ J ]. Molecular Cancer Thera-peutics,2012,11( 11) ;2495 -2504.
  • 6Ketan M. Synthesis and screening of 2-[2-(‘substi-tuted piperazine-1 -yl ) -5-phenylthiazol-4-yl ] -3-arylquinazolinone derivatives as anti cancer agents[ J].Journal of drug discovery and therapeutics, 2013,1(7):84 -89.
  • 7赵圣印,邵志宇,谢志雄.3-哌嗓基-吲哚马来酰亚胺化合物及其制备和应用[P]. CN102 924 437,2013.
  • 8万红贵,郭一丹,蔡恒,郑伟刚.S-腺苷甲硫氨酸研究进展及市场应用分析[J].现代生物医学进展,2008,8(10):1951-1955. 被引量:6
  • 9张逸伟,刘子奇,林东恩.新型5'-脱氧核苷衍生物的合成[J].合成化学,2012,20(3):349-351. 被引量:1
  • 10张贵琴,王志敏,郑爱萍.核苷类抗乙型肝炎病毒药物研究进展[J].国际药学研究杂志,2013,40(1):8-13. 被引量:16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部